CN102872335A - Externally used Chinese medicine preparation for curing diabetic foot and preparation method thereof - Google Patents
Externally used Chinese medicine preparation for curing diabetic foot and preparation method thereof Download PDFInfo
- Publication number
- CN102872335A CN102872335A CN2012103196452A CN201210319645A CN102872335A CN 102872335 A CN102872335 A CN 102872335A CN 2012103196452 A CN2012103196452 A CN 2012103196452A CN 201210319645 A CN201210319645 A CN 201210319645A CN 102872335 A CN102872335 A CN 102872335A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- radix
- chinese medicine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 132
- 208000008960 Diabetic foot Diseases 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 238000011282 treatment Methods 0.000 claims abstract description 61
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 21
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 21
- 241001446509 Psoralea Species 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims description 48
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 239000000843 powder Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 241000628997 Flos Species 0.000 claims description 20
- 241000903946 Clematidis Species 0.000 claims description 19
- 241000237636 Pheretima Species 0.000 claims description 16
- 241000717739 Boswellia sacra Species 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- 241001057584 Myrrha Species 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 14
- 239000002552 dosage form Substances 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000002674 ointment Substances 0.000 claims description 11
- 239000003053 toxin Substances 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 9
- 229940040145 liniment Drugs 0.000 claims description 9
- 239000000865 liniment Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 229940099259 vaseline Drugs 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 241000219295 Portulaca Species 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000007670 refining Methods 0.000 claims description 6
- 230000003203 everyday effect Effects 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000000571 coke Substances 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000001802 infusion Methods 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 229940098465 tincture Drugs 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 2
- 239000000469 ethanolic extract Substances 0.000 claims description 2
- 239000012567 medical material Substances 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 208000025865 Ulcer Diseases 0.000 abstract description 40
- 231100000397 ulcer Toxicity 0.000 abstract description 40
- 230000035876 healing Effects 0.000 abstract description 14
- 239000000463 material Substances 0.000 abstract description 12
- 239000004863 Frankincense Substances 0.000 abstract description 10
- 206010063560 Excessive granulation tissue Diseases 0.000 abstract description 7
- 210000001126 granulation tissue Anatomy 0.000 abstract description 7
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 230000012010 growth Effects 0.000 abstract description 3
- 230000008338 local blood flow Effects 0.000 abstract description 3
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 241001676573 Minium Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000234609 Portulaca oleracea Species 0.000 abstract 1
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 244000007853 Sarothamnus scoparius Species 0.000 abstract 1
- 244000299492 Thespesia populnea Species 0.000 abstract 1
- 235000009430 Thespesia populnea Nutrition 0.000 abstract 1
- 230000003321 amplification Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 229940105847 calamine Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229910052864 hemimorphite Inorganic materials 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 235000014692 zinc oxide Nutrition 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 137
- 210000004369 blood Anatomy 0.000 description 131
- 208000027418 Wounds and injury Diseases 0.000 description 55
- 206010052428 Wound Diseases 0.000 description 47
- 230000001737 promoting effect Effects 0.000 description 45
- 208000002193 Pain Diseases 0.000 description 31
- 230000007812 deficiency Effects 0.000 description 30
- 230000036407 pain Effects 0.000 description 30
- 230000017531 blood circulation Effects 0.000 description 29
- 230000000694 effects Effects 0.000 description 29
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 27
- 201000010099 disease Diseases 0.000 description 25
- 210000003734 kidney Anatomy 0.000 description 25
- 210000002683 foot Anatomy 0.000 description 23
- 206010012601 diabetes mellitus Diseases 0.000 description 22
- 230000006870 function Effects 0.000 description 18
- 206010028851 Necrosis Diseases 0.000 description 17
- 206010040943 Skin Ulcer Diseases 0.000 description 17
- 210000004204 blood vessel Anatomy 0.000 description 17
- 230000017074 necrotic cell death Effects 0.000 description 17
- 231100000019 skin ulcer Toxicity 0.000 description 16
- 230000006378 damage Effects 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 210000003205 muscle Anatomy 0.000 description 14
- 230000029663 wound healing Effects 0.000 description 14
- 238000005469 granulation Methods 0.000 description 13
- 230000003179 granulation Effects 0.000 description 13
- 208000014674 injury Diseases 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 230000001717 pathogenic effect Effects 0.000 description 12
- 230000015271 coagulation Effects 0.000 description 11
- 238000005345 coagulation Methods 0.000 description 11
- 241000700199 Cavia porcellus Species 0.000 description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 10
- 208000003251 Pruritus Diseases 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 210000003141 lower extremity Anatomy 0.000 description 10
- 230000004089 microcirculation Effects 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 241000700159 Rattus Species 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 9
- 210000003414 extremity Anatomy 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 208000037920 primary disease Diseases 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 208000033809 Suppuration Diseases 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 230000036285 pathological change Effects 0.000 description 8
- 231100000915 pathological change Toxicity 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 230000017423 tissue regeneration Effects 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 7
- 239000011505 plaster Substances 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 231100000419 toxicity Toxicity 0.000 description 7
- 230000001988 toxicity Effects 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 240000005373 Panax quinquefolius Species 0.000 description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000008506 pathogenesis Effects 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 230000001047 pyretic effect Effects 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 206010017711 Gangrene Diseases 0.000 description 5
- 206010053615 Thermal burn Diseases 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 239000002390 adhesive tape Substances 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 230000036770 blood supply Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 230000008520 organization Effects 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010007882 Cellulitis Diseases 0.000 description 4
- 206010014080 Ecchymosis Diseases 0.000 description 4
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 4
- 229930182566 Gentamicin Natural products 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 208000031975 Yang Deficiency Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 238000002266 amputation Methods 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000035617 depilation Effects 0.000 description 4
- 230000002951 depilatory effect Effects 0.000 description 4
- 230000000249 desinfective effect Effects 0.000 description 4
- 230000000916 dilatatory effect Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- 235000001727 glucose Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 201000001119 neuropathy Diseases 0.000 description 4
- 230000007823 neuropathy Effects 0.000 description 4
- 230000037311 normal skin Effects 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 208000033808 peripheral neuropathy Diseases 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000003371 toe Anatomy 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 3
- 206010053567 Coagulopathies Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000035602 clotting Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000001804 debridement Methods 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000000887 face Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000003673 groundwater Substances 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 208000013210 hematogenous Diseases 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000003119 painkilling effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000010201 sheng-ji-san Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000004906 toe nail Anatomy 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000001113 umbilicus Anatomy 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010012665 Diabetic gangrene Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 240000001624 Espostoa lanata Species 0.000 description 2
- 235000009161 Espostoa lanata Nutrition 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 2
- 206010027336 Menstruation delayed Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 206010047642 Vitiligo Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- -1 before card see Substances 0.000 description 2
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000003677 hemocyte Anatomy 0.000 description 2
- 229940000351 hemocyte Drugs 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 210000004276 hyalin Anatomy 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- YEXPOXQUZXUXJW-UHFFFAOYSA-N oxolead Chemical group [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000013138 pruning Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 210000002465 tibial artery Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000216 vascular lesion Toxicity 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 229910000010 zinc carbonate Inorganic materials 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FLNXBVJLPJNOSI-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 FLNXBVJLPJNOSI-UHFFFAOYSA-N 0.000 description 1
- QTQGHKVYLQBJLO-UHFFFAOYSA-N 4-methylbenzenesulfonate;(4-methyl-1-oxo-1-phenylmethoxypentan-2-yl)azanium Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.CC(C)CC(N)C(=O)OCC1=CC=CC=C1 QTQGHKVYLQBJLO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000000774 Cunila origanoides Species 0.000 description 1
- 235000018274 Cunila origanoides Nutrition 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000014866 Dictamnus albus Nutrition 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000202567 Fatsia japonica Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Hydrocortisone Natural products O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061213 Iatrogenic injury Diseases 0.000 description 1
- 206010021718 Induced labour Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010051235 Madarosis Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 208000018526 Narcotic-Related disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241001274631 Rubus pectinellus Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960002233 benzalkonium bromide Drugs 0.000 description 1
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 125000006268 biphenyl-3-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C(*)=C([H])C([H])=C1[H] 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 229910001748 carbonate mineral Inorganic materials 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 229960002544 cloperastine Drugs 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000003017 ductus arteriosus Anatomy 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960001401 hydrocortisone sodium succinate Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 229940116314 ketaject Drugs 0.000 description 1
- 229940039412 ketalar Drugs 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960000349 nitrofural Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 201000005040 opiate dependence Diseases 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 229940125395 oral insulin Drugs 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000004796 pathophysiological change Effects 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002315 pressor effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000000917 skin toxin Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Group | The example number | Cure | Take a turn for the better | Invalid | Total effectively % |
Treatment group | 50 | 42(84)﹡ | 5(10) | 3(6) | 94%﹡ |
Matched group | 50 | 34(68) | 6(12) | 10(20) | 80% |
Group | The example number | 30d | 30-60d | 60-90d | 90-150d |
Matched group | 50 | 15 | 22 | 10 | 3 |
Treatment group | 50 | 7 | 15 | 18 | 10 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210319645.2A CN102872335B (en) | 2012-08-31 | 2012-08-31 | Externally used Chinese medicine preparation for curing diabetic foot and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210319645.2A CN102872335B (en) | 2012-08-31 | 2012-08-31 | Externally used Chinese medicine preparation for curing diabetic foot and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102872335A true CN102872335A (en) | 2013-01-16 |
CN102872335B CN102872335B (en) | 2014-06-18 |
Family
ID=47474005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210319645.2A Active CN102872335B (en) | 2012-08-31 | 2012-08-31 | Externally used Chinese medicine preparation for curing diabetic foot and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102872335B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103656372A (en) * | 2013-10-07 | 2014-03-26 | 刘景文 | Diabetic foot ointment |
CN105327058A (en) * | 2015-11-02 | 2016-02-17 | 中国人民解放军第四军医大学 | Anti-infection heal-promoting ointment for diabetic feet and preparation method thereof |
CN107441158A (en) * | 2017-08-11 | 2017-12-08 | 荆门市东宝区化金生物制品厂 | One kind is treated deep skin and festered(Diabetic complication)Exempt from the decoction and manufacture skill of amputation |
CN115770285A (en) * | 2022-09-08 | 2023-03-10 | 山东欣悦健康科技有限公司 | Traditional Chinese medicine external liniment for treating diabetic gangrene and preparation method thereof |
-
2012
- 2012-08-31 CN CN201210319645.2A patent/CN102872335B/en active Active
Non-Patent Citations (2)
Title |
---|
《中国中医药现代远程教育》 20101031 刘希德 "糖尿病足中药外用方整理研究" 第180页 1-10 第8 卷, 第20 期 * |
刘希德: ""糖尿病足中药外用方整理研究"", 《中国中医药现代远程教育》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103656372A (en) * | 2013-10-07 | 2014-03-26 | 刘景文 | Diabetic foot ointment |
CN103656372B (en) * | 2013-10-07 | 2015-02-25 | 刘景文 | Diabetic foot ointment |
CN105327058A (en) * | 2015-11-02 | 2016-02-17 | 中国人民解放军第四军医大学 | Anti-infection heal-promoting ointment for diabetic feet and preparation method thereof |
CN107441158A (en) * | 2017-08-11 | 2017-12-08 | 荆门市东宝区化金生物制品厂 | One kind is treated deep skin and festered(Diabetic complication)Exempt from the decoction and manufacture skill of amputation |
CN115770285A (en) * | 2022-09-08 | 2023-03-10 | 山东欣悦健康科技有限公司 | Traditional Chinese medicine external liniment for treating diabetic gangrene and preparation method thereof |
CN115770285B (en) * | 2022-09-08 | 2024-02-06 | 山东欣悦健康科技有限公司 | A topical Chinese medicinal liniment for treating diabetic gangrene, and its preparation method |
Also Published As
Publication number | Publication date |
---|---|
CN102872335B (en) | 2014-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203B (en) | External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof | |
CN102048894B (en) | Traditional Chinese medicine composition for treating burn and preparation method thereof | |
CN102091258B (en) | Chinese medicinal composition for dispelling scars and preparation method thereof | |
WO2017206758A1 (en) | Topical pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof | |
CN103751663B (en) | A kind of Chinese medicine for external application treating anal eczema and preparation method thereof | |
CN103751633B (en) | A kind of Chinese medicine composition and its preparation method treating Varicose veins of lower extremity | |
CN102861287B (en) | Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof | |
CN102872335B (en) | Externally used Chinese medicine preparation for curing diabetic foot and preparation method thereof | |
CN102772712B (en) | Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot | |
CN104857290A (en) | Traditional Chinese medicine disinfection ointment for treating scalds and burns and preparation method thereof | |
CN106806758A (en) | A kind of Chinese medicine preparation for treating acne | |
CN102846824B (en) | Traditional Chinese medicinal composition for treating cold dampness blood stasis blocking channel type diabetic feet, and its preparation method | |
CN105477129A (en) | External-use plaster for psoriasis and preparation method thereof | |
CN107137471A (en) | A kind of Traditional Chinese medicine used as analgesic composition and its preparation method and application | |
CN103721138B (en) | A kind of traditional Chinese medicine for external application and its preparation method treating rosacea | |
CN103751708A (en) | Traditional Chinese medicine external preparation for treating varix of lower limb and preparation method thereof | |
CN106166209B (en) | For promoting I phase, II phase pressure sore healing, the antiphlogistic powder of Bedsore prevention III phase | |
CN104623057A (en) | Pharmaceutical composition for treating diabetic feet and application pf pharmaceutical composition | |
CN104306734B (en) | Treat diabetic gangrene externally applied ointment preparation and preparation method thereof | |
CN104623304A (en) | Lotion for treating chronic skin ulcer caused by damp-heat and toxicity accumulation and preparation method of lotion | |
CN103721141A (en) | External preparation for treating chronic eczema of scrotum and preparation method thereof | |
CN103142727A (en) | Chinese herbal medicine composition for treating burning and scalding of human body | |
CN101244174B (en) | Medicine for treating angiitis and preparation thereof | |
CN103948907A (en) | External traditional Chinese medicine powder capable of effectively treating chilblain and freezing injury and preparation method thereof | |
CN105362944A (en) | Traditional Chinese medicine ointment for treating orthopedics sprain and contusion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. Free format text: FORMER OWNER: YANG GAOLIN Effective date: 20140520 |
|
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhao Inventor after: Lin Ling Inventor after: Sun Xianghong Inventor after: Sun Wei Inventor before: Sun Xianghong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266033 QINGDAO, SHANDONG PROVINCE TO: 266071 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: SUN XIANGHONG TO: ZHANG ZHAO LIN LING SUN XIANGHONG SUN WEI |
|
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140520 Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Applicant after: Qingdao Huaren Technology Incubator Co., Ltd. Address before: 266033 No. 138, Liu Liu Road, Sifang District, Shandong, Qingdao Applicant before: Yang Gaolin |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151204 Address after: 516699 No. 4, Lane No. 1, Xiangzhou, Shanwei, Guangdong Patentee after: Huang Xiansun Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Patentee before: Qingdao Huaren Technology Incubator Co., Ltd. |
|
CB03 | Change of inventor or designer information |
Inventor after: Huang Xiansun Inventor before: Zhang Zhao Inventor before: Lin Ling Inventor before: Sun Xianghong Inventor before: Sun Wei |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190715 Address after: 510470 third industrial zone, man town and low village, Baiyun District, Guangdong, Guangzhou Patentee after: Baicaotang pharmaceutical Limited by Share Ltd Address before: 516699 No. 4, Lane No. 1, Xiangzhou, Shanwei, Guangdong Patentee before: Huang Xiansun |
|
TR01 | Transfer of patent right |